Vanda Pharmaceuticals Inc. (LON:0LKB)
London · Delayed Price · Currency is GBP · Price in USD 5.55
+0.13 (2.38%)
At close: Oct 24, 2025
Vanda Pharmaceuticals Market Cap
Vanda Pharmaceuticals has a market cap or net worth of 243.5 million as of October 24, 2025. Its market cap has increased by 21.73% in one year.
Market Cap
243.50M
Enterprise Value
7.87M
Revenue
148.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.55
Market Cap Chart
Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from 119.67M to 243.50M, an increase of 103.49%. That is a compound annual growth rate of 3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 243.50M | 9.15% |
| Dec 31, 2024 | 223.09M | 17.04% |
| Dec 29, 2023 | 190.61M | -45.08% |
| Dec 30, 2022 | 347.09M | -46.23% |
| Dec 31, 2021 | 645.56M | 22.64% |
| Dec 31, 2020 | 526.37M | -20.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.46B |
| HSBC Holdings | 169.14B |
| Shell | 159.91B |
| Unilever | 115.84B |
| Rolls-Royce Holdings | 92.79B |
| Rio Tinto Group | 88.76B |
| British American Tobacco p.l.c. | 82.97B |
| GSK plc | 66.45B |